Clincosm LogoSign in Get a demo

hepatocellular carcinoma

Showing 1 - 25 of 1,403
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma, Liver Function, Postoperative Complications Trial (Vitamin D, Placebo)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Vitamin D
  • Placebo
  • (no location specified)
Jun 4, 2023

Radiomics, Hepatocellular Carcinoma, TACE Trial in Guangzhou (Sorafenib, Lenvatinib)

Active, not recruiting
  • Radiomics
  • +4 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Jun 3, 2023

Hepatocellular Carcinoma Trial in Nanjing (hypovolemic phlebotomy)

Recruiting
  • Hepatocellular Carcinoma
  • hypovolemic phlebotomy
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Jun 1, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Candonilimab, Bevacizumab)

Withdrawn
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Jun 1, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Atezolizumab, Bevacizumab, HAIC with FOLFOX)

Recruiting
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
May 24, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Cadonilimab, transjugular intrahepatic portosystemic shunt (TIPS))

Not yet recruiting
  • Hepatocellular Carcinoma
  • Cadonilimab
  • transjugular intrahepatic portosystemic shunt (TIPS)
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 30, 2023

The ImmunoXXL Study

Recruiting
  • Hepatocellular Carcinoma
  • Liver Transplantation
  • Milano, MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
May 25, 2023

Liver Cancer, Tumor Recurrence, Hepatocellular Carcinoma Trial in Bologna (Hypothermic oxygenated Perfusion - HOPE)

Not yet recruiting
  • Liver Cancer
  • +4 more
  • Hypothermic oxygenated Perfusion - HOPE
  • Bologna, Italy
    IRCCS Azienda Ospedaliero-Universitaria di Bologna
May 16, 2023

Hepatocellular Carcinoma Trial in Shanghai (M-TACE)

Enrolling by invitation
  • Hepatocellular Carcinoma
  • M-TACE
  • Shanghai, Shanghai, China
    Department of Interventional Radiology, Zhongshan Hospital, Fuda
May 24, 2023

Hepatocellular Carcinoma Trial in Aarhus (18F-FDGal PET/CT or PET/MRI)

Not yet recruiting
  • Hepatocellular Carcinoma
  • 18F-FDGal PET/CT or PET/MRI
  • Aarhus, Denmark
    Aarhus University Hospital
May 15, 2023

Hepatocellular Carcinoma Trial in Hangzhou (PM8002, FOLFOX regimen)

Recruiting
  • Hepatocellular Carcinoma
  • PM8002
  • FOLFOX regimen
  • Hangzhou, Zhejiang, China
    Cancer Hospital of The University of Chinese Academy of Sciences
May 19, 2023

Hepatocellular Carcinoma Trial in Guangzhou (HAIC, Zoledronic acid)

Recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • Zoledronic acid
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
May 10, 2023

Prognostic Biomarker, Liver Transplantation, Diagnostic Biomarker Trial in Gent (HCCRecurrencePrognosticScore,

Recruiting
  • Prognostic Biomarker
  • +3 more
  • HCCRecurrencePrognosticScore
  • HCCRecurrenceDiagnosticScore
  • Gent, Belgium
    Ghent University Hospital
May 10, 2023

Hepatocellular Carcinoma Trial in China (Anlotinib HCl capsules, Penpulimab injection, Anlotinib HCl capsules -matching ,

Recruiting
  • Hepatocellular Carcinoma
  • Anlotinib hydrochloride capsules, Penpulimab injection
  • Anlotinib hydrochloride capsules -matching placebo, Penpulimab injection -matching placebo
  • Bengbu, Anhui, China
  • +66 more
May 15, 2023

Process for Hepatocellular Carcinoma

Not yet recruiting
  • Hepatocellular Carcinoma
    • (no location specified)
    May 5, 2023

    Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

    Not yet recruiting
    • Melanoma
    • +16 more
    • Darlinghurst, New South Wales, Australia
    • +3 more
    May 12, 2023

    Hepatocellular Carcinoma Trial in Beijing (Lenvatinib Plus Tislelizumab, Transarterial Chemoembolization(TACE))

    Recruiting
    • Hepatocellular Carcinoma
    • Lenvatinib Plus Tislelizumab
    • Transarterial Chemoembolization(TACE)
    • Beijing, Beijing, China
      Nan Zhang
    Apr 22, 2023

    Hepatocellular Carcinoma Trial in Munich, Würzburg (durvalumab, tremelimumab, bevacizumab)

    Recruiting
    • Hepatocellular Carcinoma
    • durvalumab, tremelimumab, bevacizumab
    • Munich, Germany
    • +2 more
    May 3, 2023

    Hepatocellular Carcinoma Trial in Philadelphia (Hydroxychloroquine, Lipiodol, Placebo)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Philadelphia, Pennsylvania
      Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
    Apr 21, 2023

    Prognostic Models for HCC Based on Tumor Micronecrosis

    Recruiting
    • Hepatocellular Carcinoma
    • observing whether HCC patients having tumor micronecrosis
    • Hangzhou, Zhejiang, China
      the First Affiliated Hospital, School of Medicine, Zhejiang Univ
    Apr 27, 2023

    Magnetic Resonance Imaging, Hepatocellular Carcinoma, Screening Trial in Lausanne (MRI)

    Recruiting
    • Magnetic Resonance Imaging
    • +3 more
    • MRI
    • Lausanne, Vaud, Switzerland
      Lausanne University Hospital
    Apr 12, 2023

    Cell-free DNA From Junction of Hepatitis B Virus Integration in

    Active, not recruiting
    • Hepatocellular Carcinoma
      • Taipei, Taiwan
        National Taiwan University Hospital
      Apr 10, 2023

      Hepatocellular Carcinoma Trial in Worldwide (Budigalimab, Livmoniplimab, Lenvatinib)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • Prescott Valley, Arizona
      • +58 more
      Apr 10, 2023

      Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial (Liquid Biopsy)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • +4 more
      • Liquid Biopsy
      • (no location specified)
      Apr 18, 2023

      Hepatocellular Carcinoma, Transcatheter Arterial ChEmoembolization, Regorafenib Trial in Guangzhou (TACE, Regorafenib)

      Recruiting
      • Hepatocellular Carcinoma
      • +2 more
      • Guangzhou, Guangdong, China
        FirstSunYetSen
      Apr 12, 2023